Cargando…
Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease
Metabolic acidosis, defined as a plasma or serum bicarbonate concentration <22 mmol/L, is a frequent consequence of chronic kidney disease (CKD) and occurs in ~10–30% of patients with advanced stages of CKD. Likewise, in patients with a kidney transplant, prevalence rates of metabolic acidosis ra...
Autores principales: | Imenez Silva, Pedro H, Unwin, Robert, Hoorn, Ewout J, Ortiz, Alberto, Trepiccione, Francesco, Nielsen, Rikke, Pesic, Vesna, Hafez, Gaye, Fouque, Denis, Massy, Ziad A, De Zeeuw, Chris I, Capasso, Giovambattista, Wagner, Carsten A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713149/ https://www.ncbi.nlm.nih.gov/pubmed/34718761 http://dx.doi.org/10.1093/ndt/gfab216 |
Ejemplares similares
-
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor
por: Liabeuf, Sophie, et al.
Publicado: (2023) -
Brain dysfunction in tubular and tubulointerstitial kidney diseases
por: Viggiano, Davide, et al.
Publicado: (2021) -
Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence?
por: Bikbov, Boris, et al.
Publicado: (2021) -
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease
por: Giannakou, Konstantinos, et al.
Publicado: (2023) -
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
por: Liabeuf, Sophie, et al.
Publicado: (2021)